Related Experiment Video
Updated: Aug 24, 2026

Interactions with and Membrane Permeabilization of Brain Mitochondria by Amyloid Fibrils
Published on: September 28, 2019
Association of FMF-related (MEFV) point mutations with secondary and FMF amyloidosis
M Pamir Atagunduz1, Serhan Tuglular, Gulcin Kantarci
1Department of Rheumatology, Marmara University School of Medicine, Istanbul, Turkey.
Background:
Familial Mediterranean fever (FMF) is the major cause of AA amyloidosis in Turkey. M694V mutation in MEFV gene was suggested to be associated with severe clinical features and amyloidosis of FMF.
Methods:
In this study, the frequencies of three FMF-related MEFV mutations (M694V, M680I and V726A) were investigated in FMF patients with (AA-FMF, n = 37) and without amyloidosis (non-AA-FMF, n = 35), in patients with secondary amyloidosis related to non-FMF inflammatory conditions (S-AA, n = 19) and in a non-inflammatory control group (n = 185) by molecular genetic studies using polymerase chain reaction with the ARMS (amplification refractory mutation system) method.
Results:
Both AA and non-AA-FMF patients had significantly higher MEFV mutations compared to non-inflammatory controls (81 and 62.7% respectively vs. 4.2%, p = 0.0001). AA-FMF patients carried significantly more MEFV mutations than non-AA-FMF patients (p = 0.01). M694V was the most common mutation in both FMF groups (63.5 vs. 51.4%), however allele frequency (p = 0.17) and the number of homozygous patients for this mutation did not differ between the groups (p = 0.77). Although lower compared to FMF patients, S-AA patients also had a significantly higher incidence of MEFV mutations than non-inflammatory controls (21 vs. 4.2%) (p = 0.0002). M694V was the only MEFV mutation in this group.
Conclusion:
MEFV mutations are found to be increased both in FMF and non-FMF associated secondary amyloidosis in our study; however, no clear association between M694V and amyloidosis is observed, except in the non-FMF group. Our results suggest that MEVF mutations may also serve as a severity marker for other inflammatory conditions.
Insights
Familial Mediterranean Fever (FMF) patients show increased MEFV gene mutations, particularly M694V. While MEFV mutations are linked to amyloidosis in FMF, the M694V variant
Area of Science:
- Genetics and Molecular Biology
- Rheumatology and Immunology
- Nephrology and Urology
Background:
- Familial Mediterranean Fever (FMF) is a primary cause of AA amyloidosis in Turkey.
- The M694V mutation in the MEFV gene is suspected to correlate with severe FMF clinical manifestations and amyloidosis.
Purpose of the Study:
- To investigate the frequencies of three MEFV gene mutations (M694V, M680I, V726A) in FMF patients with and without amyloidosis.
- To compare MEFV mutation prevalence in FMF-associated amyloidosis, non-FMF secondary amyloidosis, and healthy controls.
Main Methods:
- Molecular genetic analysis using polymerase chain reaction with the ARMS method.
- Genotyping of MEFV mutations (M694V, M680I, V726A) in four groups: AA-FMF (n=37), non-AA-FMF (n=35), secondary AA amyloidosis (S-AA, n=19), and controls (n=185).
Main Results:
- MEFV mutations were significantly more frequent in both AA-FMF (81%) and non-AA-FMF (62.7%) patients compared to controls (4.2%).
- AA-FMF patients exhibited a higher prevalence of MEFV mutations than non-AA-FMF patients (p=0.01).
- M694V was the most common mutation in FMF groups, but its allele frequency and homozygous status did not significantly differ between amyloidosis and non-amyloidosis groups.
Conclusions:
- MEFV mutations are elevated in both FMF-related and non-FMF secondary amyloidosis.
- A direct association between the M694V mutation and amyloidosis in FMF was not clearly established, though observed in the non-FMF group.
- MEFV mutations may indicate disease severity in other inflammatory conditions beyond FMF.
More Related Videos
08:22A Robust Polymerase Chain Reaction-based Assay for Quantifying Cytosine-guanine-guanine Trinucleotide Repeats in Fragile X Mental Retardation-1 Gene
Published on: September 16, 2019
08:59Real-Time Fluorescent Measurement of Synaptic Functions in Models of Amyotrophic Lateral Sclerosis
Published on: July 16, 2021
Related Concept Videos
Amyloid Fibrils
Amyloid deposits were observed as early as 1639 in the liver and the spleen. In 1854, Rudolph Virchow performed iodine staining, normally used to...
Amyloid Fibrils
Amyloid deposits were observed as early as 1639 in the liver and the spleen. In 1854, Rudolph Virchow performed iodine staining, normally used to...